Synlogic (SYBX)
(Delayed Data from NSDQ)
$1.55 USD
-0.01 (-0.32%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $1.55 0.00 (0.00%) 4:56 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Brokerage Reports
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 21 - 40 ( 111 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
2021 Financials; Mid-Stage Phenylketonuria Data in Focus; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Multiple Data Catalysts in 2022; Strong Balance Sheet; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Synthetic Biotic Publication; Cash Replenished; Modulating PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1618 Proof-of-Concept Data Approaching; 2Q21 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1934 Next-Generation Phenylketonuria Candidate Enters Clinic; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Roche Collaboration Announced; Solid Balance Sheet; Lowering PT to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage Due to Realignment of Analyst Resources
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB8802 Phase 1 Trial Initiated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Updates on Multiple Fronts; 2Q20 Financials Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Collaboration Agreement Terminated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R